Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-29FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) submitted by Haleon US Holdings LLC. This action…
-
FDA approval · 2023-10-20FDA Approved: COXANTO — Original Application (SOLA Pharmaceuticals, LLC)
The FDA approved COXANTO (oxaprozin) from SOLA Pharmaceuticals in its original application, enabling its use for pain and inflammation assoc…
-
FDA approval · 2023-10-11FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved Naproxen and Esomeprazole Magnesium (ScieGen Pharmaceuticals) under Original Application. The combination is indicated for reli…
-
FDA approval · 2023-09-07FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Indomethacin submitted by Amneal Pharmaceuticals LLC.
-
FDA approval · 2023-08-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, LLC. This action approves changes under an appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-17FDA Approved: OXAPROZIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for Oxaprozin submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2023-06-07FDA Approved: MELOXICAM — Original Application (XLCare Pharmaceuticals, Inc.)
The FDA approved the original application for MELOXICAM (meloxicam), a generic version manufactured by XLCare Pharmaceuticals, Inc., under A…
-
FDA approval · 2023-05-05FDA Approved: IBUPROFEN — Supplemental Application (Winco Foods, LLC)
The FDA approved a supplemental application for a generic ibuprofen product developed by Winco Foods, LLC.
-
FDA approval · 2023-02-21FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) submitted by Haleon US Holdings LLC. This action…
-
FDA approval · 2023-02-03FDA Approved: PIROXICAM — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for piroxicam from Strides Pharma Science Limited. This action completes another regulatory submissi…
-
FDA approval · 2022-12-22FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the fixed-dose combination diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc. The…
-
FDA approval · 2022-11-23FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) from Haleon US Holdings LLC to expand the labeling f…
-
FDA approval · 2022-11-15FDA Approved: CAREONE IBUPROFEN — Supplemental Application (American Sales Company)
The FDA approved a supplemental application for CAREONE IBUPROFEN (ibuprofen) filed by American Sales Company under ANDA077349.
-
FDA approval · 2022-11-09FDA Approved: DAYPRO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Daypro (oxaprozin) from Pfizer Laboratories Div Pfizer Inc, indicating an approved update re…
-
FDA approval · 2022-10-28FDA Approved: NAPROXEN SODIUM — Original Application (Camber Consumer Care Inc)
FDA approved Naproxen Sodium generic from Camber Consumer Care Inc under an Original Application (ANDA211065).
-
FDA approval · 2022-10-06FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s Naproxen and Esomeprazole Magnesium as an Original Application (ANDA213699), providing a generic versi…
-
FDA approval · 2022-09-28FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for ARTHRITIS PAIN RELIEVER (diclofenac sodium) by Publix Super Markets Inc. This action approves ch…
-
FDA approval · 2022-09-15FDA Approved: CELECOXIB — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved a supplemental application for a generic celecoxib product from Westminster Pharmaceuticals, expanding access under ANDA210…
-
FDA approval · 2022-09-06FDA Approved: NAPROXEN SODIUM — Supplemental Application (CVS)
The FDA approved a supplemental application for naproxen sodium sponsored by CVS.
-
FDA approval · 2022-07-18FDA Approved: FENOPRON TM — Original Application (Galt Pharmaceuticals, LLC)
FDA approved Fenoprofen calcium as a generic tablet under an original ANDA submitted by Galt Pharmaceuticals, LLC.
-
FDA approval · 2022-06-07FDA Approved: NAPROXEN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber's naproxen generic original application for Naproxen. This generic NSAID is approved for relief of pain and inflammation…
-
FDA approval · 2022-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Apotex Corp.)
FDA approved Apotex Corp's original application for diclofenac sodium tablets, a generic NSAID. This approval enables Apotex to market a gen…
-
FDA approval · 2022-03-22FDA Approved: IBUPROFEN — Supplemental Application (Aurohealth LLC)
The FDA approved a supplemental application for ibuprofen filed by Aurohealth LLC, authorizing the generic ibuprofen product.
-
FDA approval · 2022-03-18FDA Approved: BROMFENAC — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for bromfenac from Aurobindo Pharma Limited, enabling a generic bromfenac product to enter the market.…
-
FDA approval · 2022-03-11FDA Approved: NAPROXEN — Supplemental Application (Granules India Ltd)
FDA approved a supplemental application for naproxen sodium granules from Granules India Ltd, resulting in an approved supplemental request …